High cytokine levels at admission are associated with fatal outcome in patients with necrotizing fasciitis

European Cytokine Network

Volumn 15, Issue 2, 2004, Pages 135-138

  Lungstras Bufler, Kathrin ^a   Bufler, Philip ^a   Abdullah, Rabiatu ^b   Rutherford, Christine ^b   Endres, Stefan ^c   Abraham, Edward ^a   Dinarello, Charles A ^a   Rodriguez, Robert M ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b HIGHLAND HOSPITAL   (United States)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Aggressive treatment; Cellulitis; Fatal outcome; Necrotizing fasciitis; Proinflammatory cytokines

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; ARTICLE; BLOOD LEVEL; CELLULITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG USE; FATALITY; FEMALE; HOSPITAL ADMISSION; HUMAN; LEUKOCYTE; MALE; NECROTIZING FASCIITIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADULT; CELLULITIS; CYTOKINES; FASCIITIS, NECROTIZING; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SIALOGLYCOPROTEINS;

EID: 3242763005     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Franci KR, Lamaute HR, Davis JM, Pizzi WF. 1993. Implications of risk factors in necrotizing fasciitis. Am Surg 59: 304.
2. Childers BJ, Potyondy LD, Nachreiner R, Rogers FR, Childers ER, Oberg KC, Hendricks DL, Hardesty RA. 2002. Necrotizing fasciitis: a fourteen-year retrospective study of 163 consecutive patients. Am Surg 68: 109.
3. McHenry CR, Piotrowski JJ, Petrinic D, Malangoni MA. 1995. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg 221: 558.
4. Singh G, Ray P, Sinha SK, Adhikary S, Khanna SK. 1996. Bacteriology of necrotizing infections of soft tissues. Aust N Z J Surg 66: 747.
5. Cunningham JD, Silver L, Rudikoff D. 2001. Necrotizing fasciitis: a plea for early diagnosis and treatment. Mt Sinai J Med 68: 253.
6. Fustes-Morales A, Gutierrez-Castrellon P, Duran-Mckinster C, Orozco-Covarrubias L, Tamayo-Sanchez L, Ruiz-Maldonado R. 2002. Necrotizing fasciitis: report of 39 pediatric cases. Arch Dermatol 138:893.
7. Schmid MR, Kossmann T, Duewell S. 1998. Differentiation of necrotizing fasciitis and cellulitis using MR imaging. AJR Am J Roentgenol 170: 615.
8. Seal DV. 2001. Necrotizing fasciitis. Curr Opin Infect Dis 14: 127.
9. Majeski J, Majeski E. 19997. Necrotizing fasciitis: improved survival with early recognition by tissue biopsy and aggressive surgical treatment. South Med J 90: 1065.
10. Elliott DC, Kufera JA, Myers RA. 1996. Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg 224: 672.
11. Deaver DR. 1995. A new non-isotopic detection system for immunoassays. Nature 377: 758.
12. Puren AJ, Razeghi P, Fantuzzi G, Dinarello CA. 1998. Interleukin-18 enhances lipopolysaccharide-induced interferon-gamma production in human whole blood cultures. J Infect Dis 178: 1830.
13. Casey LC, Balk RA, Bone RC. 1993. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119: 771.
14. Norrby-Teglund A, Chatellier S, Low DE, McGeer A, Green K, Kotb M. 2000. Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur J Immunol 30: 3247.
15. Norrby-Teglund A, Thulin P, Gan BS, Kotb M, McGeer A, Andersson J, Low DE. 2001. Evidence for superantigen involvement in severe group a streptococcal tissue infections. J Infect Dis 184: 853.
16. Dinarello CA. 1996. Biologic basis for interleukin-1 in disease. Blood 87: 2095.
17. Feezor RJ, Oberholzer C, Baker HV, Novick D, Rubinstein M, Moldawer LL, Pribble J, Souza S, Dinarello CA, Ertel W, Oberholzer A. 2003. Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect Immun 71: 5803.